1.00
3.85%
-0.04
Finanzdaten der Immunic Inc-Aktie (IMUX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.14%
23.88
|
23.38 | 23.57 | 25.02 | 27.25 |
Operating Income/Loss |
2.14%
-23.88
|
-23.38 | -23.57 | -25.02 | -27.25 |
Nonoperating Income/Loss |
415.26%
-5.703
|
1.809 | 0.801 | 1.022 | 1.979 |
Income/Loss From Continuing Operations Before Tax |
37.14%
-29.58
|
-21.57 | -22.77 | -24.00 | -25.27 |
Income/Loss From Continuing Operations After Tax |
37.14%
-29.58
|
-21.57 | -22.77 | -24.00 | -25.27 |
Net Income/Loss
|
37.14%
-29.58
|
-21.57 | -22.77 | -24.00 | -25.27 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
104.76K%
97.30
|
0.0928 | 44.57 | 44.43 | 43.66 |
Diluted Average Shares |
104.76K%
97.30
|
0.0928 | 44.57 | 44.43 | 43.66 |
Basic Earnings Per Share |
37.50%
-0.30
|
-0.48 | -0.51 | -0.54 | -0.58 |
Diluted Earnings Per Share |
37.50%
-0.30
|
-0.48 | -0.51 | -0.54 | -0.58 |
Common Stock Dividends |
-
|
- | - | - | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):